Bagsværd, Denmark, 3 October 2016 - In continuation of the company's announcements dated 3 February 2016 and 5 August 2016 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 30 September 2016 owned 29,476,648 of its own B shares of DKK 0.20, corresponding to a total nominal value of DKK 5,895,330 or 1.2% of the total share capital.
In the third quarter of 2016 a total of 11,107,003 B shares were repurchased, and 8,000 B shares were disposed to employees in connection with employee incentive programmes.
|Anne Margrethe Hauge||+45 4442 firstname.lastname@example.org|
|Ken Inchausti (US)||+1 609 786 email@example.com|
|Peter Hugreffe Ankersen||+45 3075 firstname.lastname@example.org|
|Melanie Raouzeos||+45 3075 email@example.com|
|Hanna Ögren||+45 3079 firstname.lastname@example.org|
|Kasper Veje (US)||+1 609 235 email@example.com|
Last updated on: 04/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.